We are live on
!
Find out more
TE
Tema ETFs Portfolio holdings
AUM
$3.09B
1-Year Est. Return
72.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
+72.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$241M
AUM Growth
–
Cap. Flow
+$255M
Cap. Flow
% of AUM
105.95%
Top 10 Holdings %
Top 10 Hldgs %
27.78%
Holding
148
New
148
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rockwell Automation
ROK
|
+$8.98M |
| 2 |
Applied Industrial Technologies
AIT
|
+$8.46M |
| 3 |
Clean Harbors
CLH
|
+$7.13M |
| 4 |
Timken Company
TKR
|
+$6.85M |
| 5 |
Primoris Services
PRIM
|
+$6.82M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 46.25% |
| 2 | Healthcare | 42.59% |
| 3 | Technology | 3.29% |
| 4 | Materials | 2.86% |
| 5 | Financials | 2.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Genmab
GMAB
$17.6B
| $1.23M | 0.51% |
+58,935
| New | +$1.29M |
|
52
GE Aerospace
GE
$364B
| $1.2M | 0.5% |
+7,221
| New | +$1.29M |
|
53
Structure Therapeutics
GPCR
$3.45B
| $1.2M | 0.5% |
+44,343
| New | +$1.57M |
|
54
Visa
V
$682B
| $1.16M | 0.48% |
+3,659
| New | +$1.1M |
|
55
Arrowhead Research
ARWR
$10.5B
| $1.16M | 0.48% |
+61,503
| New | +$1.27M |
|
|
ONC
56
BeOne Medicines Ltd
ONC
$32.4B
| $1.15M | 0.48% |
+6,249
| New | +$1.28M |
|
57
Rocket Pharmaceuticals
RCKT
$376M
| $1.14M | 0.47% |
+90,985
| New | +$1.37M |
|
58
Merck
MRK
$315B
| $1.13M | 0.47% |
+11,342
| New | +$1.17M |
|
59
Madrigal Pharmaceuticals
MDGL
$12.8B
| $1.12M | 0.46% |
+3,620
| New | +$1.02M |
|
|
SWTX
60
DELISTED
SpringWorks Therapeutics
SWTX
| $1.11M | 0.46% |
+30,811
| New | +$1.08M |
|
61
Intercontinental Exchange
ICE
$79B
| $1.11M | 0.46% |
+7,428
| New | +$1.18M |
|
62
Guardant Health
GH
$20.7B
| $1.1M | 0.46% |
+36,120
| New | +$1.02M |
|
63
Mineralys Therapeutics
MLYS
$2.39B
| $1.1M | 0.46% |
+89,529
| New | +$1.17M |
|
|
DAWN
64
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.09M | 0.45% |
+85,761
| New | +$1.19M |
|
65
West Pharmaceutical
WST
$25.3B
| $1.04M | 0.43% |
+3,180
| New | +$1M |
|
66
Fair Isaac
FICO
$29.2B
| $1.04M | 0.43% |
+521
| New | +$1.11M |
|
67
S&P Global
SPGI
$133B
| $950K | 0.39% |
+1,907
| New | +$968K |
|
|
NUVL
68
DELISTED
Nuvalent
NUVL
| $909K | 0.38% |
+11,617
| New | +$1.08M |
|
|
AKRO
69
DELISTED
Akero Therapeutics
AKRO
| $894K | 0.37% |
+32,150
| New | +$974K |
|
70
Agios Pharmaceuticals
AGIO
$2.36B
| $846K | 0.35% |
+25,735
| New | +$1.21M |
|
|
EXAS
71
DELISTED
Exact Sciences
EXAS
| $843K | 0.35% |
+15,008
| New | +$934K |
|
72
Viking Therapeutics
VKTX
$4.31B
| $813K | 0.34% |
+20,215
| New | +$1.15M |
|
73
Sherwin-Williams
SHW
$81.7B
| $800K | 0.33% |
+2,353
| New | +$878K |
|
|
NARI
74
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $755K | 0.31% |
+14,790
| New | +$727K |
|
75
Celldex Therapeutics
CLDX
$2.77B
| $745K | 0.31% |
+29,480
| New | +$801K |
|
Similar funds
DCM
HCM
KF
TCG
PC
CAM
VBA
FI
Tema ETFs's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Tema ETFs, which disclosed 148 positions worth $241M. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Rockwell Automation: 31,912 shares worth $9.12M.
By sector, the portfolio is most concentrated in Industrials at 46% of assets, followed by Healthcare and Technology.
- Tema ETFs's largest Q4 2024 buy was Rockwell Automation: 31,912 shares worth $9.12M.
- Tema ETFs's ten largest holdings make up 28% of its $241M portfolio in Q4 2024.
- Tema ETFs disclosed 148 positions in Q4 2024, its first 13F filing on record.
Based on Tema ETFs's 13F filing for Q4 2024, filed 14 Feb 2025.